Among the markers used to characterize B-ALL in cytoplasm, CD79a and CD22 presented the highest positivity rate (100%), followed by CD19 in the cell membrane (86.6%). This evidence concerns the gene CD79A and precursor B-cell acute lymphoblastic leukemia.